TRIM77BP

Across TCGA pan-cancer cohorts, TRIM77BP RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated TRIM77BP data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher TRIM77BP RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated TRIM77BP expression acts as an unfavorable survival marker.

STAD, LUAD, and SARC are the cancer types where TRIM77BP RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.379	0.732	<.001	54	view →
LUAD	DFS	Tertile	IV	0.333	0.671	.048	18	view →
SARC	DFS	Tertile	All	0.094	0.632	<.001	12	view →
UCEC	OS	Tertile	All	0.876	0.928	.028	12	view →
GBM	OS	Tertile	All	0.075	0.416	.011	9	view →
LUSC	DFS	Tertile	II,III,IV	0.139	0.663	.027	9	view →
PCPG	DFS	Tertile	All	0.535	0.935	.040	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

TRIM77BP–STAD (DFS)

Open the STAD breakdown →